In Non-Small Cell Lung Carcinoma (NSCLC) patients, high levels of AGO2 phosphorylation at S417 (pS417-AGO2), which is surface exposed but not positioned in close proximity of the RNA-binding channel, correlates with a decreased prognosis. Here, AGO2 is linked to non-small cell lung carcinoma.